Pascal Biosciences Inc
XTSX:PAS
Cash Flow Statement
Cash Flow Statement
Pascal Biosciences Inc
| Nov-2020 | Nov-2021 | Nov-2022 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(1)
|
(1)
|
(0)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
|
| Other Non-Cash Items |
(0)
|
0
|
0
|
|
| Change in Working Capital |
0
|
0
|
0
|
|
| Cash from Operating Activities |
(1)
N/A
|
(1)
+29%
|
(0)
+76%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
0
|
1
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
|
| Other |
0
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
0
N/A
|
1
+32%
|
0
-75%
|
|
| Change in Cash | ||||
| Net Change in Cash |
(0)
N/A
|
0
N/A
|
0
+76%
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(1)
N/A
|
(1)
+29%
|
(0)
+76%
|
|